PRESIDENT, CLINICALDIAGNOSTICS · Natera, Inc. · Common Stock
Side
A
Value
—
Shares
1,774
Price
—
Executed
Mar 9, 2026
Disclosed
Mar 11, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 9 executedMar 11, 2026 disclosed
NTRA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 1.2% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 18 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Moshkevich Solomon filed this Form 4 reporting a grant or award of NTRA on Mar 9, 2026. It became public on Mar 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRESIDENT, CLINICALDIAGNOSTICS
Moshkevich Solomoncik:0002010019
Issuer
Natera, Inc.cik:0001604821
Revision history · 0
No field has changed since this record was first ingested.
